- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
AstraZeneca PLC (AZN)
AstraZeneca PLC stock price live, this page displays LON AZN stock exchange data. View the AZN premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the AstraZeneca PLC real time stock price chart below.
What Is the AstraZeneca PLC Stock Price Today?
The AstraZeneca PLC stock price today is 12,492.0.
What Is the Stock Symbol for AstraZeneca PLC?
The stock symbol for AstraZeneca PLC is "AZN."
What Stock Exchange Does AstraZeneca PLC Trade On?
AstraZeneca PLC is listed and trades on the London stock exchange.
Is AstraZeneca PLC a Good Stock to Buy?
Determining whether AstraZeneca PLC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the AZN quote. (ISIN: GB0009895292)
What Is the AstraZeneca PLC Stock Price Today?
The AstraZeneca PLC stock price today is 12,492.0.
What Is the Stock Symbol for AstraZeneca PLC?
The stock symbol for AstraZeneca PLC is "AZN."
What Stock Exchange Does AstraZeneca PLC Trade On?
AstraZeneca PLC is listed and trades on the London stock exchange.
Is AstraZeneca PLC a Good Stock to Buy?
Determining whether AstraZeneca PLC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the AZN quote. (ISIN: GB0009895292)
12,492.0
+92.0(+0.74%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
12,398.0
12,614.0
52 wk Range
10,784.0
15,730.0
AZN is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
12,398.012,614.0
52 wk Range
10,784.015,730.0
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.93%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.93%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
AZN Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Prominent player in the Pharmaceuticals industry
Quantumscape stock hits 52-week low at $4.76- Investing.com
- Quantumscape stock hits 52-week low at $4.76
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
AstraZeneca PLC Earnings Call Summary for Q2/2026
- AstraZeneca Q2 2026 EPS of $2.63 beat estimates by 6%, though revenue of $15.38B missed forecasts by 0.45% amid generic competition pressures.
- Revenue grew 11% excluding Farxiga and Brilinta losses; oncology remained key growth driver with double-digit gains across major regions.
- Company reiterated 2026 guidance for mid-to-high single-digit revenue growth and low double-digit EPS growth at constant currency rates.
- Pipeline advances highlighted with positive phase III gastric cancer data; 25 phase III readouts expected over next 18 months supporting growth.
- Management reaffirmed $80B revenue target by 2030; shares rose 1.06% pre-market to $12,804 on solid execution despite transition headwinds.
Last Updated: 07/27/2026, 08:50 PM
Read Full TranscriptEarnings
Latest Release
Jul 27, 2026
EPS / Forecast
2.63 / 2.48
Revenue / Forecast
15.38B / 15.45B
Compare AZN to Peers and Sector
Metrics to compare | AZN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipAZNPeersSector | |
|---|---|---|---|---|
P/E Ratio | 24.4x | 23.8x | −0.4x | |
PEG Ratio | 0.94 | 0.32 | 0.00 | |
Price/Book | 5.1x | 5.1x | 2.6x | |
Price / LTM Sales | 4.2x | 4.8x | 3.0x | |
Upside (Analyst Target) | 29.0% | 32.6% | 57.0% | |
Fair Value Upside | Unlock | 10.9% | 8.0% | Unlock |
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company offers Imjudo, Datroway, Iressa, Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Crestor, Andexxa, Onglyza, Symlin, XIGDUO XR, Atacand, Atacand HCT, Atacand Plus, Farxiga/Forxiga, Plendil, Modip, Splendil, Munobal, Flodil, Tenormin, Tenormine, Prenormine, Atenol, Zestril, Brilinta/Brilique, Komboglyze, Qtern, Wainua, Byetta, Lokelma, Seloken ZOK, Toprol-XL, Betaloc ZOK, XIGDUO, Accolate, Accoleit, Vanticon, Bricanyl Respules, Eklira Genuair/Tudorza/Bretaris, Pulmicort Turbuhaler, Symbicort Turbuhaler, Airsupra, Bricanyl Turbuhaler, Fasenra, Rhinocort, Tezspire, Bevespi Aerosphere, Daliresp/Daxas, Oxis Turbuhaler, Saphnelo, Breztri Aerosphere, Duaklir Genuair, Pulmicort Respules, and Symbicort pMDI. It also provides Beyfortus, Kavigale, Evusheld, Fluenz/FluMist, Synagis, Kanuma, Ultomiris, Koselugo, Voydeya, Soliris, Strensiq, Nexium, and other medicines. The company offers its products for ocology, cardiovascular, renal and metabolism, respiratory & immunology, vaccines and immune, and therapies rare diseases. It serves primary and specialty care physicians through distributors and local representative offices in the United Kingdom, the Americas, rest of Europe, Asia, Africa, and Australasia. It has a strategic agreement with Tempus and Pathos to develop the largest multimodal foundation model in oncology; CSPC Pharmaceutical Group Limited to advance the discovery and development of novel oral candidates, with the potential to treat diseases across multiple indications; and Nucs AI Inc. to develop AI-driven Response Prediction for Therapeutic Radioconjugates. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the AstraZeneca (AZN) Stock Price Today?
The AstraZeneca stock price today is 12,492.0 GBP.
What Stock Exchange Does AstraZeneca Trade On?
AstraZeneca is listed and trades on the London Stock Exchange.
What Is the Stock Symbol for AstraZeneca?
The stock symbol for AstraZeneca is "AZN."
Does AstraZeneca Pay Dividends? What’s The Current Dividend Yield?
The AstraZeneca dividend yield is 1.93%.
What Is the AstraZeneca Market Cap?
As of today, AstraZeneca market cap is 193.23B GBP.
What Is AstraZeneca's Earnings Per Share (TTM)?
The AstraZeneca EPS (TTM) is 6.7.
When Is the Next AstraZeneca Earnings Date?
AstraZeneca will release its next earnings report on Oct 30, 2026.
From a Technical Analysis Perspective, Is AZN a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has AstraZeneca Stock Split?
AstraZeneca has split 0 times.
How Many Employees Does AstraZeneca Have?
AstraZeneca has 96100 employees.
What is the current trading status of AstraZeneca (AZN)?
As of Sep 25, 2026, AstraZeneca (AZN) is trading at a price of 12,492.0 GBP, with a previous close of 12,400.0 GBP. The stock has fluctuated within a day range of 12,398.0 GBP to 12,614.0 GBP, while its 52-week range spans from 10,784.0 GBP to 15,730.0 GBP.
What Is AstraZeneca (AZN) Price Target According to Analysts?
The average 12-month price target for AstraZeneca is 15,992.8 GBP, with a high estimate of 20665.12671155 GBP and a low estimate of 11931.00461457 GBP. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +28.02% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.